《盈警響號》明樑控股集團(08152.HK)料中期虧損收窄至700萬元
明樑控股集團(08152.HK)發盈警,料6月底止中期虧損自去年同期的950萬元收窄至700萬元。公司表示,中期錄得虧損主要由於期內本港未有大型隧道鑽挖項目展開,以及全球建築活動的進度受到新型肺炎疫情爆發所影響。
虧損收窄則主要由於新型肺炎疫情較去年有所緩和而建築活動重啟,因此歐洲及美洲市場的銷售有所改善,致收入增加約15.8%,毛利率亦稍有改善。期內人民幣與歐元匯率於該期間相對穩定,因此錄得匯兌收益約40萬元,去年同期匯兌虧損則為約170萬元。惟期內銷售費用上升100萬元,主因於運費水平因航運市場自去年下半年起出現紊亂而意外增加,導致向海外客戶銷售的運費上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.